ljc 10627 has been researched along with Hematologic Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Azuma, R; Harada, H; Mori, H; Niikura, H; Omine, M; Sakai, H; Sanada, M; Shimamoto, K | 1 |
1 trial(s) available for ljc 10627 and Hematologic Diseases
| Article | Year |
|---|---|
[Multicenter, retrospective study of biapenem in the treatment of 1090 cases with hematological diseases complicated with infections].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Female; Hematologic Diseases; Humans; Male; Middle Aged; Retrospective Studies; Thienamycins; Treatment Outcome; Young Adult | 2013 |
1 other study(ies) available for ljc 10627 and Hematologic Diseases
| Article | Year |
|---|---|
[Clinical evaluation of biapenem for febrile neutropenia in patients with hematological disorders].
Topics: Anemia, Aplastic; Carbapenems; Fever; Hematologic Diseases; Humans; Infusions, Intravenous; Leukemia, Lymphoid; Leukemia, Myeloid; Lymphoma; Myelodysplastic Syndromes; Neutropenia; Thienamycins; Treatment Outcome | 2007 |